新凤鸣 20260303 摘要 行业底部确认，PTA 与长丝价差进入修复通道，预计 3 月底完成春节累 库去化并开启提价周期。 短纤业务优于长丝，凭借"一口价"模式与国内第一市占率，2025 年 单位价差约 150-200 元。 2026 年产能扩张清晰：短纤拟增 60 万吨（6 月及 10 月），长丝 10 月 拟增 30 万吨，PTA 增量受限。 埃及基地规划 60 万吨产能，首套装置定点布局非洲，预计 2026 年 5-6 月 ODI 获批后开工。 差异化产品占比超 50%（含细规格），特种纤维约 10%，部分品种售 价较同行高 20-50 元/吨。 经营策略以 300 元/吨价差为稳健平衡点，凭借成本优势在低价差区间 保持强于小产能的盈利韧性。 生物基新材料万吨级产线计划 2026 年底投产，化学法再生已具阶段性 进展，定位未来战略增长极。 Q&A 能否介绍公司 2025 年整体经营表现、2026 年开年以来的经营近况，并对后 续行业走势作出判断？ 2026 年开年以来，春节前后行业头部企业对长丝产能进行了按比例减产；春 节后首周行业库存水平较往年处于更合理区间，并出现一定幅度下滑。该库存 基数有利于 ...

Group 1 - The core viewpoint of the articles highlights the collaboration between the company and China Merchants Group to advance the commercialization of bio-based new materials in various sectors such as highways, bridges, construction, containers, and ships [1] - The company is accelerating the testing and product validation work, aiming to expand commercialization channels through demonstration projects [1] - The company's core development directions for the next 3-5 years include the research and development of high-value utilization technology for biomass waste, the expansion of bio-based polyamide and its composite materials, and the construction of an industrial ecosystem [1] Group 2 - The company has adjusted the expected operational status date for its "annual production of 500,000 tons of bio-based hexamethylenediamine and 900,000 tons of bio-based polyamide project" from December 31, 2025, to December 31, 2027, while the project construction content remains unchanged [2]

发酵车间（呼和浩特市科学技术局供图） 呼和浩特依托独特的资源禀赋与要素比较优势，合力打造以合成生物为特色的生物医药产业集群，形成生物发酵、生物疫苗、中（蒙）医药完整产业链条。 目前，全市规上工业企业34家，累计获得药品注册批件602个，产业集聚效应与发展活力持续凸显。此次5亿产业基金的落地，将进一步推动首府生物医药产 业补链延链固链强链，加速推动打造国内领先的合成生物产业标杆城市。 此次基金的正式落地，不仅为呼和浩特生物医药产业注入新的资金与资源动能，更让当地合成生物产业再次站上战略风口。未来，随着基金投资项目的逐步 落地与赋能效应的释放，呼和浩特市有望加速实现从"资源优势"向"发展优势"的转型升级，进一步缩短与全国顶尖生物医药产业集群的差距，为打造全国领 先的生物医药产业高地奠定坚实基础。（来源：呼和浩特市科学技术局） 从定位来看，该基金为"产业赋能型投资平台"，不仅对企业提供资金支持，也将依托华润集团在大健康、科技与新兴产业、大消费等多元化的产业基础和资 源，加之呼和浩特市在合成生物产业上的政策、资源、载体三位一体的发展优势，为当地企业提供从技术研发、中试转化、产能落地到市场拓展的全链条赋 能和支持，促进 ...

Investment Rating - The report maintains an "Accumulate" rating for the company with a target price of 33.30 CNY, compared to the current price of 26.30 CNY [6]. Core Insights - The company's main products continue to see growth in both production and sales, with ongoing projects in diol, bio-based new materials, and light stabilizers ensuring long-term growth [2]. - The company demonstrated resilience in Q3 performance, with a slight decline in revenue and net profit year-on-year, but maintained a stable gross margin and net margin [12]. - The company has a rich project reserve and is steadily advancing capacity construction, which is expected to enhance its competitive position in the market [12]. Financial Summary - Total revenue for 2023 is projected at 2,181 million CNY, with a slight increase to 2,220 million CNY in 2024, and further growth to 2,900 million CNY by 2027, reflecting a CAGR of approximately 13.4% from 2024 to 2027 [4]. - Net profit attributable to the parent company is expected to decline from 250 million CNY in 2023 to 207 million CNY in 2024, before recovering to 292 million CNY by 2027 [4]. - The company's earnings per share (EPS) are forecasted to be 1.20 CNY in 2023, decreasing to 1.00 CNY in 2024, and then gradually increasing to 1.40 CNY by 2027 [4]. Project Development - The company is actively pursuing the construction of various projects, including a 35,000 tons/year light stabilizer project expected to be completed by December 2024, and a new 25,000 tons/year light stabilizer project to enhance product variety and competitiveness [12]. - Technological innovations are being implemented to improve product performance and reduce reliance on traditional fossil resources, with several patents filed and granted in 2024 [12].

Core Insights - The fifth International New Materials Industry Conference will be held in Bengbu, Anhui from November 20 to 23, marking the city's fifth consecutive year as the host of this significant event in the new materials sector [2][4] - New materials are defined as advanced functional materials that outperform traditional materials, serving as a cornerstone for high-end manufacturing and technology industries [2][6] - Bengbu, known as the "City of Materials," has established a comprehensive development system for the new materials industry, achieving significant advancements in various subfields such as silicon-based and bio-based new materials [2][7] Event Overview - The conference has attracted approximately 6,500 participants from both domestic and international new materials sectors over the past four years, resulting in 408 signed projects with a total investment of 383.9 billion yuan [4] - This year's theme, "New Technology, New Materials, New Future," focuses on key areas such as silicon-based new materials and high-performance composite materials, featuring prominent guests from various sectors [4][5] Strategic Goals - The conference aims to facilitate technological self-reliance by connecting global research forces and bridging the gap between basic research and industrial application [5] - It will support national strategic initiatives by promoting resource sharing and collaborative industrial division within the Yangtze River Delta region [5] - The event will expand international cooperation opportunities, attracting participation from Fortune 500 companies and creating platforms for both domestic and global resource exchange [5] Industry Development - Bengbu is recognized for its competitive advantages in silicon-based new materials, housing the only national innovation center and key laboratory in this field [7][9] - The city has developed a complete industrial chain for new displays, advanced photovoltaics, and specialty glass, becoming the only city in China capable of producing all types of glass required for the display industry [9][10] - Bengbu's small-sized display module market holds the largest global market share, and the city has established the first domestic production line for copper indium gallium selenide photovoltaic glass [10] Economic Impact - The total output value of 411 new materials enterprises in Bengbu has surpassed 66 billion yuan, contributing to the city's industrial transformation and modernization [14] - In 2024, Bengbu's GDP is projected to reach 231.3 billion yuan, reflecting a growth rate of 5.2% compared to the previous year [14][15]

Core Viewpoint - The company reported its 2025 semi-annual results, showing a slight decline in revenue but an increase in net profit, indicating resilience in profitability despite challenging market conditions [1]. Financial Performance - In H1 2025, the company achieved revenue of 1.116 billion yuan, a year-on-year decrease of 1.69%, while net profit attributable to shareholders was 108 million yuan, up 0.22% year-on-year. The non-recurring net profit was 106 million yuan, reflecting a 9.08% increase year-on-year. Earnings per share (EPS) stood at 0.52 yuan [1]. - For Q2 2025, revenue was 572 million yuan, down 1.92% year-on-year but up 5.00% quarter-on-quarter. Net profit for Q2 was 61 million yuan, a year-on-year increase of 17.64% and a quarter-on-quarter increase of 30.77% [1]. Product Performance - The company experienced stable growth in product sales, with a notable increase in the production and sales of dimethyl succinate, while the sales of plasticizers declined [2]. - In H1 2025, the production of dimethyl succinate was 60,300 tons (up 10.98% year-on-year), with sales of 59,700 tons (up 6.01% year-on-year). The production of plasticizers was 26,400 tons (up 0.35% year-on-year), but sales fell to 23,900 tons (down 13.72% year-on-year). The production of fatty alcohols was 25,600 tons (up 6.30% year-on-year), with sales of 26,000 tons (up 12.35% year-on-year) [2]. Pricing and Profitability - Despite a decline in product prices, the overall profit margin improved, primarily due to a greater reduction in raw material costs compared to product prices. The high-margin product PCDL contributed to the overall increase in gross margin [3]. - In H1 2025, the average prices for dimethyl succinate, plasticizers, and fatty alcohols were 7,709 yuan/ton (down 1.50% year-on-year), 8,419 yuan/ton (down 15.79% year-on-year), and 15,369 yuan/ton (down 10.89% year-on-year) respectively. The overall gross margin increased to 17.71%, up 1.12 percentage points year-on-year, while the net margin was 9.64%, up 0.18 percentage points year-on-year [3]. Business Expansion and Capacity - The company is expanding its business and capacity with multiple projects nearing production, including a 35,000 tons/year hindered amine light stabilizer project that has entered trial production, and ongoing construction of a 30,000 tons/year glycol project and a 25,000 tons/year hindered amine light stabilizer project [4]. - As a leading player in niche chemical products, the company is well-positioned to benefit from cyclical market reversals, with a global leading capacity in mixed dimethyl succinate and domestic leading capacity in fatty alcohols and DCP products [4]. Investment Outlook - The company is a leader in the fine chemicals sector, with significant production capacity in dimethyl succinate, fatty alcohols, and DCP products, benefiting from integrated and scaled advantages. The entry into the bio-based sector opens a second growth curve [5]. - Updated revenue forecasts for 2025-2027 are 2.227 billion yuan, 2.760 billion yuan, and 3.513 billion yuan respectively, with net profits of 244 million yuan, 347 million yuan, and 437 million yuan. The corresponding EPS estimates are 1.17 yuan, 1.67 yuan, and 2.10 yuan, with price-to-earnings ratios of 18, 12, and 10 times based on the closing price of 20.82 yuan on September 11 [5].

Core Viewpoint - Taiyuan City is focusing on industrial transformation and the cultivation of strategic emerging industries, enhancing innovation and establishing a green manufacturing system to drive high-quality economic development [1][31]. Group 1: Macroeconomic Analysis - Taiyuan's GDP for 2024 is projected to be CNY 541.887 billion, with a growth rate of 1.2%. The primary, secondary, and tertiary industries contribute CNY 4.785 billion, CNY 166.671 billion, and CNY 370.431 billion respectively, with the tertiary sector growing by 1.6% [2][4]. - The proportion of strategic emerging industries in Taiyuan's industrial output is increasing, with a 2024 forecast showing a 37.3% contribution to the total industrial output, up 1.4 percentage points from the previous year [4]. Group 2: Investment Trends - Fixed asset investment in Taiyuan is expected to grow by 0.5% in 2024, with 136 ongoing projects valued over CNY 1 billion, representing 35.9% of total investment [6]. - Industrial investment is projected to account for 27.7% of total investment, with a significant increase of 24.7% year-on-year [6]. Group 3: Industrial Structure - Taiyuan is constructing a modern industrial system centered around the "1233" key industrial chain system, which includes nine major industrial chains contributing approximately 70% of the city's industrial output [10][31]. - The "1233" system focuses on high-end metal materials, advanced carbon-based materials, and advanced biological materials, among others, with 118 key enterprises involved [10][31]. Group 4: Innovation and R&D - In 2023, Taiyuan's R&D expenditure reached CNY 12.79 billion, ranking first in Shanxi Province, indicating a strong focus on innovation [8]. - The city is implementing four major projects to enhance innovation capabilities, including optimizing the innovation ecosystem and promoting the transformation of innovative results [8]. Group 5: Key Industries - The high-end metal materials industry is a pillar of Taiyuan's economy, with significant products including special steel and new magnesium alloys, generating CNY 118.3 billion in revenue in 2023 [19][20]. - The carbon-based materials industry is leveraging local coal resources and advanced research capabilities, with a focus on both traditional and cutting-edge carbon materials [25][27]. - The advanced biological materials and biopharmaceutical industry is developing rapidly, focusing on bio-based new materials and recombinant human collagen protein [29]. Group 6: Policy Framework - Taiyuan has introduced several policies to support high-quality development, including plans for digital transformation and the establishment of advanced manufacturing bases [16][18]. - The city aims to achieve significant results in industrial high-quality development by 2025, enhancing its competitive advantages [16].